Aeterna Zentaris to Announce Fourth Quarter and Full Year 2012 Financial and Operating Results on March 21, 2013

About this update from Cosciens Biopharma Inc.

[{"type":"text","content":"\n\n\n\n\n\nQUEBEC CITY, March 12, 2013 /CNW Telbec/ - Aeterna Zentaris Inc.\n (NASDAQ: AEZS) (TSX: AEZ) (the \"Company\") will announce its fourth\n quarter and full-year 2012 financial and operating results on Thursday,\n March 21, 2013, after market close. The Company will host a conference\n call the next morning, Friday, March 22, 2013 at 8:30 a.m. (Eastern\n Time), to discuss these results.\n\n\nParticipants may access the live webcast via the Company's website at www.aezsinc.com in the \"Newsroom\" section, or by telephone using the following numbers:\n in Canada, 514-807-9895 or 647-427-7450, outside Canada, 888-231-8191.\n A replay of the webcast will also be available on the Company's website\n for a period of 30 days.\n\n\nAbout Aeterna Zentaris \n\n\nAeterna Zentaris is an oncology and endocrinology drug development\n company currently investigating treatments for various unmet medical\n needs. The Company's pipeline encompasses compounds at all stages of\n development, from drug discovery through to marketed products. For more\n information, please visit www.aezsinc.com.\n\nSOURCE: AETERNA ZENTARIS INC.\n\n\n Investor Relations Ginette Beaudet Vallières Investor Relations Coordinator (418) 652-8525 ext. [email protected] Media Relations Paul Burroughs Director of Communications (418) 652-8525 ext. [email protected] \n","length":1788,"tagName":"div"}]

More updates from Cosciens Biopharma Inc.